JMP Securities analyst Michael King initiated coverage of Idera Pharmaceuticals Inc. (Nasdaq: IDRA) with a Market Outperform rating and a price target of $8 sending the stock price up 40 cents to close at $2.49.
Idera Pharmaceuticals initiated with Market Perform
March 22, 2017 at 17:36 PM EDT